IPAD-DB ID | S01253 |
Name | 2-Phenylethyl cinnamate |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 7 H 1 6 O 2 |
Molecular Weight | 252.31 g/mol |
IUPAC Name | 2-phenylethyl(E)-3-phenylprop-2-enoate |
InChI | InChI=1S/C17H16O2/c18-17(12-11-15-7-3-1-4-8-15)19-14-13-16-9-5-2-6-10-16/h1-12H, 13-14H2/b12-11+ |
InChIKey | MJQVZIANGRDJBT-VAWYXSNFSA-N |
Canonical SMILES | C1=CC=C(C=C1)CCOC(=O)C=CC2=CC=CC=C2 |
PubChem CID | 5369459 |
DrugBank Accession Number | - |
CAS Registry Number | 103-53-7 |
Molecular Weight(Computed by SwissADME) | 252.31 |
Hac(Computed by SwissADME) | 19 |
Volume(Computed by ADMETlab 2.0) | 281.964 |
Density(Computed by ADMETlab 2.0) | 0.894 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 14 |
Flexibility(Computed by ADMETlab 2.0) | 0.429 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -4.612 |
LogD(Computed by ADMETlab 2.0) | 4.068 |
logP(Computed by ADMETlab 2.0) | 4.263 |
TPSA(Computed by SwissADME) | 26.3 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 0 |
Rotatable Bonds(Computed by SwissADME) | 6 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -4.59 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |